Skip to content
Search

Latest Stories

Independents could make £52k with hub and spoke dispensing: HubRx  

HubRx has launched a new benefits calculator that shows the average independent community pharmacy can create £52k more profit per annum through hub and spoke dispensing.

The company aims to change the existing business model by freeing up time for pharmacy teams so pharmacists and technicians can focus on providing more clinical services to patients.


The calculator also takes account of improved purchasing margins through HubRx’s ability to make high-volume purchases not currently available to independents and small chain community pharmacies.

Additionally, a further benefit is the estimated £30k one-off capital release from stock that independents will no longer need to hold which could be used to enhance the pharmacy to support clinical services.

HubRx has calculated that an independent pharmacy dispensing 7,500 items per month and optimising hub and spoke for 70 per cent of those items could make an extra £52k a year.

CEO of HubRx, Daniel Lee, said: “This calculator will enable community pharmacists to recognise the potential that hub and spoke offers in expanding their service offering. Our purpose-built facility will give them time-saving automated dispensing that’s previously only been available to larger pharmacy chains.

“We know the decision whether to access hub and spoke is a complex one. With this calculator we want to show the benefits hub and spoke can have in terms of freeing up skilled time to offer more professionally and financially rewarding clinical services especially with the backdrop of flat funding and an expansion of NMS and cardiovascular testing.”

The benefits calculator can be tailored to individual size and need so pharmacists can see the potential of freeing up capacity through hub and spoke.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less